The CoTCCC has defined a set of preferred characteristics for intraosseous infusion devices. The current list is as follows: Approved by the FDA, the sternum as the main insertion site (clearly labeled for the insertion site). Great bone insertion site (clearly labeled for the insertion site). Easily inserted without power. Compatible with the infusion of all prehospital fluid resuscitation. Latex-free. 125cc/min minimum flow. Auto-locking a once inserted. Can be removed without the need for a removal tool. Easy Training for battle or simulated environments battlefield. Compatible with other systems via a luer-lock system *. Able to stay up to 24 hours. Sterile packaging. Shock. Shelf life: 3 years minimum expiration and up to 5 years. Accessories include instructions to facilitate the training. High rate of user acceptance. Ease of use of the device in low light. Minimum possibility of injury to the supplier. Slightest possibility of retained parts of the device after removal. Unlikely to be traumatically displaced. Minimum weight. Low rate of complications in the battlefield
0 comments:
Post a Comment